The Moldovan Competition Authority investigates the actions of the Customs Service concerning attribution of tariff positions to certain pharmaceutical products (Serviciul Vamal al Republicii Moldova)

On 26 September 2013 the Moldovan Competition Authority (CC) [1] closed its investigation into the alleged anti-competitive actions of the Customs Service of the Republic of Moldova [2] concerning the determination of the tariff positions for certain imported pharmaceuticals. The CC’s investigation was prompted by a complaint submitted by the representative office of Bayer Schering in Moldova. The applicant noted that several authorized distributors of Bayer HealthCare were importing Theraflex, a drug administered to the patients with various spine and neck problems such as aches, pains and inflammations. During the period 2009-2011 Theraflex was classified as a pharmaceutical product and imported under the tariff position 3004 (8% VAT and 0% import tariff).

Access to this article is restricted to subscribers

Already Subscribed? Sign-in

Access to this article is restricted to subscribers.

Read one article for free

Sign-up to read this article for free and discover our services.

 

PDF Version

Author

Quotation

Alexandr Svetlicinii, The Moldovan Competition Authority investigates the actions of the Customs Service concerning attribution of tariff positions to certain pharmaceutical products (Serviciul Vamal al Republicii Moldova), 26 September 2013, e-Competitions Bulletin September 2013, Art. N° 64925

Visites 65

All issues

  • Latest News issue 
  • All News issues
  • Latest Special issue 
  • All Special issues